文献速递血液净化与透析

血液透析患者中无症状COVID-19感染高发:血清学筛查揭示高血清阳性率

High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.
PubMed 文献 · J Am Soc Nephrol · 2020-07-30

该研究对356例接受中心血液透析的患者进行SARS-CoV-2抗体检测,发现血清阳性率达36.2%,其中52例(40.3%)为无症状或PCR未检测到的感染,提示现行筛查策略可能低估急性感染。

要点

  • 透析患者SARS-CoV-2抗体血清阳性率高达36.2%。
  • 40.3%的血清阳性患者为无症状或PCR漏检。
  • 现行症状+PCR筛查可能低估急性感染。

核心结论

  • 中心血液透析患者SARS-CoV-2抗体血清阳性率高,且相当比例感染无症状或被PCR筛查遗漏。

研究设计与样本

  • 采用Abbott IgG assay在Architect系统检测356例接受中心血液透析患者的血清SARS-CoV-2抗体。

主要发现

  • 356例中121例有症状并接受RT-PCR检测,79例(占总数22.2%)PCR阳性。
  • 全部356例血清学检测中129例(36.2%)SARS-CoV-2抗体阳性。
  • 129例抗体阳性者中52例(40.3%)为无症状或仅PCR检测未发现。
  • 仅2例PCR确诊感染者未出现血清转换。

临床怎么用

  • 血清学筛查可补充PCR,用于评估透析单元内暴露和筛查策略效果。

局限性

  • 血清学检测不能提供患者传染性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Strategies to minimize the risk of transmission and acquisition of COVID-19 infection in patients with ESKD receiving in-center hemodialysis have been rapidly implemented across the globe. Despite these interventions, confirmed COVID-19 infection rates have been high in the United Kingdom. Prevalence of asymptomatic disease in an adult hemodialysis population has not been reported. Also, to our knowledge, the development of humoral response to SARS-CoV-2 has not been previously reported in this population. Although serologic testing does not provide information on the infectivity of patients, seroprevalence studies may enable investigation of exposure within dialysis units and hence, assessment of current screening strategies. METHODS: To investigate the seroprevalence of SARS-CoV-2 antibodies in a hemodialysis population, we used the Abbott IgG assay with the Architect system to test serum samples from 356 patients receiving in-center hemodialysis for SARS-CoV-2 antibodies. RESULTS: Of 356 patients, 121 had been symptomatic when screened before a dialysis session and received an RT-PCR test; 79 (22.2% of the total study population) tested positive for COVID-19. Serologic testing of all 356 patients found 129 (36.2%) who tested positive for SARS-CoV-2 antibodies. Only two patients with PCR-confirmed infection did not seroconvert. Of the 129 patients with SARS-CoV-2 antibodies, 52 (40.3%) had asymptomatic disease or undetected disease by PCR testing alone. CONCLUSIONS: We found a high seroprevalence of SARS-CoV-2 antibodies in patients receiving in-center hemodialysis. Serologic evidence of previous infection in asymptomatic or PCR-negative patients suggests that current diagnostic screening strategies may be limited in their ability to detect acute infection.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Clarke C, Prendecki M, Dhutia A, et al. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. J Am Soc Nephrol. 2020. PMID: 32732391. doi:10.1681/ASN.2020060827

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。